BREAST INFLAMMATORY CARCINOMA
Clinical trials for BREAST INFLAMMATORY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST INFLAMMATORY CARCINOMA trials appear
Sign up with your email to follow new studies for BREAST INFLAMMATORY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop inflammatory breast cancer in its tracks
Disease control OngoingThis study looks at whether adding the drug olaparib to standard radiation therapy helps prevent inflammatory breast cancer from coming back. About 300 people who have already had chemotherapy and mastectomy will take part. The goal is to see if the combination works better than …
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Immunotherapy combo targets stubborn inflammatory breast cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard hormone therapy can help prevent breast cancer from returning in people with a rare and aggressive type called inflammatory breast cancer. Participants had hormone receptor-positive cancer that did n…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:38 UTC